Other
Increase (Decrease) in Inventories
Alnylam Pharmaceuticals Increase (Decrease) in Inventories increased by 166.8% to $3.32M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 153.5%, from -$6.22M to $3.32M. Over 3 years (FY 2021 to FY 2024), Increase (Decrease) in Inventories shows a downward trend with a -19.9% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2017
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase may signal expected demand growth or supply chain bottlenecks, while a decrease might indicate strong sales or inventory optimization efforts.
Detailed definition
Represents the net change in the value of raw materials, work-in-progress, and finished goods held by the company. This...
Peer comparison
Standard metric for manufacturing and industrial firms; essential for evaluating inventory turnover and operational health.
Metric ID:
other_increase_decrease_in_inventoriesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.96M | $13.63M | $10.76M | -$1.93M | $9.20M | $7.88M | $18.98M | $403.00K | -$1.99M | -$4.80M | -$11.99M | -$22.00K | -$6.79M | -$5.93M | -$849.00K | -$6.22M | -$11.14M | -$4.98M | $3.32M |
| QoQ Change | — | +244.7% | -21.1% | -117.9% | +577.7% | -14.3% | +140.7% | -97.9% | -592.6% | -141.6% | -150.1% | +99.8% | <-999% | +12.8% | +85.7% | -632.0% | -79.3% | +55.3% | +166.8% |
| YoY Change | — | — | — | — | +132.6% | -42.2% | +76.4% | +120.9% | -121.6% | -160.8% | -163.2% | -105.5% | -242.3% | -23.6% | +92.9% | <-999% | -64.0% | +16.0% | +153.5% |
Range-$11.99M – $18.98M
CAGR-3.8%
Avg YoY Growth<-999%
Median YoY Growth-42.2%
Current Streak2 quarters growth
Increase (Decrease) in Inventories at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's increase (decrease) in inventories?
- Alnylam Pharmaceuticals (ALNY) reported increase (decrease) in inventories of $3.32M in Q1 2026.
- How has Alnylam Pharmaceuticals's increase (decrease) in inventories changed year-over-year?
- Alnylam Pharmaceuticals's increase (decrease) in inventories increased by 153.5% year-over-year, from -$6.22M to $3.32M.
- What is the long-term trend for Alnylam Pharmaceuticals's increase (decrease) in inventories?
- Over 3 years (2021 to 2024), Alnylam Pharmaceuticals's increase (decrease) in inventories has grown at a -19.9% compound annual growth rate (CAGR), from $26.42M to -$13.59M.
- What does increase (decrease) in inventories mean?
- The change in the total value of products and materials the company has in stock.